200 related articles for article (PubMed ID: 35350991)
1. Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies.
Izu A; Kwatra G; Madhi SA; Rigat F
BMC Med Res Methodol; 2022 Mar; 22(1):85. PubMed ID: 35350991
[TBL] [Abstract][Full Text] [Related]
2. Association of Group B Streptococcus (GBS) Serum Serotype-Specific Anticapsular Immunoglobulin G Concentration and Risk Reduction for Invasive GBS Disease in South African Infants: An Observational Birth-Cohort, Matched Case-Control Study.
Madhi SA; Izu A; Kwatra G; Jones S; Dangor Z; Wadula J; Moultrie A; Adam Y; Pu W; Henry O; Briner C; Cutland CL
Clin Infect Dis; 2021 Sep; 73(5):e1170-e1180. PubMed ID: 33341870
[TBL] [Abstract][Full Text] [Related]
3. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
[TBL] [Abstract][Full Text] [Related]
4. Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B Streptococcal disease.
Dangor Z; Kwatra G; Izu A; Khan M; Lala SG; Madhi SA
Vaccine; 2021 Nov; 39(47):6813-6816. PubMed ID: 34688499
[TBL] [Abstract][Full Text] [Related]
5. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.
Seale AC; Bianchi-Jassir F; Russell NJ; Kohli-Lynch M; Tann CJ; Hall J; Madrid L; Blencowe H; Cousens S; Baker CJ; Bartlett L; Cutland C; Gravett MG; Heath PT; Ip M; Le Doare K; Madhi SA; Rubens CE; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J; Lawn JE
Clin Infect Dis; 2017 Nov; 65(suppl_2):S200-S219. PubMed ID: 29117332
[TBL] [Abstract][Full Text] [Related]
6. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants.
Dangor Z; Kwatra G; Izu A; Adrian P; Cutland CL; Velaphi S; Ballot D; Reubenson G; Zell ER; Lala SG; Madhi SA
Vaccine; 2015 Nov; 33(48):6793-9. PubMed ID: 26478200
[TBL] [Abstract][Full Text] [Related]
7. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
[TBL] [Abstract][Full Text] [Related]
8. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
[TBL] [Abstract][Full Text] [Related]
9. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
[TBL] [Abstract][Full Text] [Related]
11. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
Seale AC; Baker CJ; Berkley JA; Madhi SA; Ordi J; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J
Vaccine; 2019 Aug; 37(35):4877-4885. PubMed ID: 31303524
[TBL] [Abstract][Full Text] [Related]
13. Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?
Lawn JE; Bianchi-Jassir F; Russell NJ; Kohli-Lynch M; Tann CJ; Hall J; Madrid L; Baker CJ; Bartlett L; Cutland C; Gravett MG; Heath PT; Ip M; Le Doare K; Madhi SA; Rubens CE; Saha SK; Schrag S; Sobanjo-Ter Meulen A; Vekemans J; Seale AC
Clin Infect Dis; 2017 Nov; 65(suppl_2):S89-S99. PubMed ID: 29117323
[TBL] [Abstract][Full Text] [Related]
14. Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches.
Absalon J; Simon R; Radley D; Giardina PC; Koury K; Jansen KU; Anderson AS
Hum Vaccin Immunother; 2022 Dec; 18(1):2037350. PubMed ID: 35240933
[TBL] [Abstract][Full Text] [Related]
15. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden.
Gonçalves BP; Procter SR; Paul P; Chandna J; Lewin A; Seedat F; Koukounari A; Dangor Z; Leahy S; Santhanam S; John HB; Bramugy J; Bardají A; Abubakar A; Nasambu C; Libster R; Sánchez Yanotti C; Horváth-Puhó E; Sørensen HT; van de Beek D; Bijlsma MW; Gardner WM; Kassebaum N; Trotter C; Bassat Q; Madhi SA; Lambach P; Jit M; Lawn JE; ; ; ;
Lancet Glob Health; 2022 Jun; 10(6):e807-e819. PubMed ID: 35490693
[TBL] [Abstract][Full Text] [Related]
16. Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections.
Dangor Z; Lala SG; Kwatra G; Madhi SA
Curr Opin Infect Dis; 2016 Jun; 29(3):262-7. PubMed ID: 26926474
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
[TBL] [Abstract][Full Text] [Related]
18. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
19. Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.
Le Doare K; Faal A; Jaiteh M; Sarfo F; Taylor S; Warburton F; Humphries H; Birt J; Jarju S; Darboe S; Clarke E; Antonio M; Foster-Nyarko E; Heath PT; Gorringe A; Kampmann B
Vaccine; 2017 May; 35(22):2970-2978. PubMed ID: 28449969
[TBL] [Abstract][Full Text] [Related]
20. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.
Dangor Z; Kwatra G; Izu A; Lala SG; Madhi SA
Expert Rev Vaccines; 2015 Jan; 14(1):135-49. PubMed ID: 25242617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
